MT2_9_Chronic Stable Angina Flashcards

(51 cards)

1
Q

What is significant CAD defined as?

A
  • CAD greater than or equal to 70% diameter stenosis of one major epicardial artery
  • greater or equal to 50% diameter stenosis from left main coronary artery
  • vasospasm, uncontrolled HTN, valvular heart disease, hypertrophic cardiomyopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define stable angina

A
  • predictable, not changing in frequency, intensity, or duration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define unstable angina

A
  • presents as rest
  • new onset (less than 2 months)
  • severe pain that is more frequent, longer duration, lower threshold
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the considerations for high risk unstable angina?

A
  • more than 20 min
  • pulmonary edema
  • hypotension
  • angina at rest w ST elevation
  • worsening MR murmur
  • s3, new worsening rales
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lifestyle modifications for CAD?

A
  • reduce cholesterol
  • reduce saturated fat
  • increase unsaturated fat
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PE requirement
Lipid Management
Diabetes management

A
  • moderate intensity 30-60min 5d/week, or vigorous for 20min, 3d/week
  • lipid management goal LDL less than 70, or high intensity statin
  • diabetes: HbA1C less than 7
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain how NSAIDs and Aspirin work

A
  • at low doses, aspirin inhibits cox-1, inhibiting clots from forming and sparing PG anti-thrombotic properties. The higher the dose, the more thrombotic patient will get.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Safest COX2 inhibitor?

Pain management strategy in CVD?

A
  • avoid, but naproxen is ok

- apap, ASA, opioids, then non COX2 selective NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the general approach to treating CSA?

A
    1. balance O2 supply and demand (increase supply, decrease demand)
    1. slow progression of the disease
    1. provide prophylaxis against thrombus formation

therefore, use

  1. an antiplatelet
  2. abtianginal/antiischemic
  3. disease modifying therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Common anti platelets used?

A
  • aspirin
  • clopidogrel
  • prasugrel
  • ticlopidine
  • ticagrelor, cangrelor, voraxapar
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What to monitor for when patient is on aspirin?

A
  • CBC
  • Platelets
  • Bleeding (GI)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When is clopidogrel most effective regarding use?

A
  • additive benefit when used in combo with aspirin for UA/NSTEMI or post-PCI
  • only used as an alternative to ASA for monotherapy in patients with CAD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Monitoring for clopidogrel?

A
  • CBC
  • Bleeding
  • DDI
  • DC 5 days prior surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

So what is the recommendation for clopidogrel use?

A
  • when ASA is absolutely CI (75mg daily)
  • combo with aspirin post PCI, refractory anginal issues despite revascularization attempts
  • anginal issues, not a candidate for revasc.
  • ACS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prasugrel efficacy/use?

Monitor

Dose

CI

DC

BBW

A
  • ONLY inpatients with ACS + PCI.
  • more effective than clopidogrel, but higher risk of bleeding
  • monitor: bleeding, CBC, plt
  • dose 60mg loading, then 10mgQD
  • CI: pts with a hx of stroke/TIA
  • DC 7-10 days before surgery
  • BBW: bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why is ticlopidine no longer used?

A
  • agranulocytosis ,plt, bleeding risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Is ticagrelor a prodrug?

What does it do? reduces the rate of ____events and vascular death in ____ vs. clopidogrel, with more ____

A

no

  • thrombotic CV events
  • ACS
  • higher major bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
For ticagrelor, avoid aspirin
DC
ADR
DDI
AVOID
Pregnancy 
Dose
A
  • doses higher than 100
  • 5 days before surgery
  • bleeding/dyspnea
  • DDI w 3A4/5 substrate
  • avoid in severe hepatic impairment
  • category C
  • 180mg PO load, 90 PO BID
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cangrelor monitoring and ADRs

Dose

A
  • monitor for bleeding, do not give with clopidogrel or prasugrel
  • preg C

NOT FOR CSA

30mcg/kg IV bolus, then 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
Vorapaxar
MOA
Indication
CI
DDI
A
  • par1 receptor antagoinst
  • oral, competitive reversible binding
  • reduce the risk of heart attacks, stroke, death, in patients with PREVIOUS MI or PAD
  • CI in CVA or TIA
  • DDI: 3A4 inhibitors and inducers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the main drugs NOT recommended in CSA? (3)

A
  • ASA + clopidogrel + warfarin (only for CAD), or in patients who had a PCI with a need for warfarin
  • dipyridamole (increases induced ischemia)

ticolpidine

22
Q

CSA anti platelet recommendations?

A
  • Aspirin
  • Clopidogrel, only when ASA is CI
  • clopidogrel + ASA in refractory ischemia or post PCI
  • ticagrelor (only if started on when pt had ACS)
  • vorapaxar for refractory patients
23
Q

What is the main role of antianginals? Name them

A

Increasing supply

- BB, CCB, Nitrates, Ranolazine

24
Q

Non cardioselective BBs

A
  • ptns (propanolol, timolol nadolol, sotalol)
25
Cardioselctive BBs
maa | metoprolol, atenolol, acebutolol
26
ISA BBs
acebutolol, pindolol, oxyprenolol
27
Lipophilicity of BBs
propanolol>metoprolol>atenolol
28
How do BBs work?
- decrease demand by decreasing HR and contractility - increase supply by increasing diastolic time and decreasing after load - blocks sympathetic effects
29
What to monitor when pt is on a BB?
- CP - HR (goal is 55-60) to lower the MVO2 - BP due to rebound HTN - EKG - Bronchospasm (if pt is on a steroid and a LABA) no BB! not even a cardioselevtive one! - cocaine alpha 1 is vasoconstriction, avoid BB because it inhibits only beta, leaving alpha
30
Should CAD patients get a BB? Depression Renal issues When is a BB CI?
- yes, w/wo prior hx of MI - all patients w IHD should get a BB - no propanolol - no atenolol - acute ischemia caused by cocaine/stimulant OD
31
For CCBs, what do we monitor for?
- HR - BP - DDI (d and v) - peripheral edema - constipation - HA, flushing, dizziness
32
For nonDHP CCB, what to look out for? CI?
- bradycardia - heart block - do not use if LVEF is less than 40% - CI in heart failure and severe AV block
33
For DHP CCB, look out for...
- reflex tachycardia | - peripheral edema
34
Sp, when are CCB indicated?
- substitute for BB or add w BB if tx is unsuccessful with a BB, no difference if DHP or NDHP - avoid short acting DHP (nifedipine)
35
What is the DOC for ischemia secondary to vasospasm. (prinzmetal) or due to cocaine/stimulant use?
CCBs!
36
What is the MOA of nitroglycerin?
- decrease in demand by decreasing preload and/or after load, decreasing wall stress - coronary artery vasodilatation, increase supply
37
Compared to BB and CCB, do nitrates affect long term outcomes?
- reduce in anginal frequency, and increase in exercise tolerance - no effect on long term patient outcomes though
38
What to monitor for nitro?
- BP - HR - Headache - nitrate free interval
39
What is the recommendation for immediate relief of angina? regarding nTG
- spray - substitute for BB or add on - SL Nitro 0.4mg q5min once, then ER if doesn't work
40
How does ranolazone work?
- inhibits late sodium from going into the cell, to decreses contractility, HR, decreasing demand. - is preferred bc it has no effects on HR and BP, so pt with a low BP may use it
41
What to monitor for ranolazine? Cyps PGP
- ADR: constpiation, NV, headache, QTc prolongation - caution in cyp3A4 inhibitors with will increase ranolazine levels (dilt,verap, azaleas, macrolides) - pgp substrates like digox will increase ranolazine levels - avoid use with other meds that cause QTc prolongation (antiarrhythmics)
42
When to recommend ranolazine? Dose?
- adjunct therapy for STABLE patients with REFRACTORY angina OR as monotherapy - dose initially 500mg PO2x, then 1000mg 2x
43
What meds are used to modify the artherosclerotic process?
ACE, ARBs, lipid lowering therapy
44
What is the MOA of ACE inhibitors?
- counteracts effects of vasoconstriction, fluid retention, cardiac remodeling, inhibiting ACEI or blocking the AT1 receptor - increases bradykinin (vasodilatory)
45
What have ACEI been shown to improve?
- long term outcomes post MI
46
When should patients recieve an ACE?
- stable CAD + DM and/or LV dysfunction including those w HTN,DM, CKD
47
What to monitor for in ACE/ARB?
- BP - Renal fx - serum K - angioedema cough, dysguesia
48
When should an ACE be initiated?
- all patents post MI, continued indefinitely | - early in stable high risk patient
49
When is an ACE inhibited?
- AKI (significant increasing SCr trend) | - severe chronic kidney disease (SCr greater than 3.0)
50
What are the lipid goals in patient with CAD?
- LDL less than70 (high risk) - TG less than 150 HDL greater than 40(m), 50(w) - TC less than 200e - high-intensity statin is recommended in ALL CAD PATIETNS regardless of LDL
51
What to monitor for a statin?
- LFT - Myopathy - CK - DDI